Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
March 10, 2020
Model-Informed Drug Development for Everolimus Dosing Selection in Pediatric Infant Patients
Francois Pierre Combes, Heidi J Einolf, Neva Coello, et al.
Journal of Pharmaceutical Sciences
|
February 6, 2019
Physiologically Based Pharmacokinetic Modeling to Supplement Nilotinib Pharmacokinetics and Confirm Dose Selection in Pediatric Patients
Tycho Heimbach, Wen Lin, Florence Hourcade-Potelleret, et al.
Clinical Pharmacokinetics
|
June 28, 2022
Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases
Ying Fei Li, Francois Pierre Combes, Matthias Hoch, et al.
Clinical Pharmacokinetics
|
August 17, 2022
Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases
Ying Fei Li, Francois Pierre Combes, Matthias Hoch, et al.
Clinical Pharmacokinetics
|
June 23, 2026
Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer
Yan Ji, Craig Wang, Francois Pierre Combes, et al.
Clinical Pharmacokinetics
|
September 7, 2024
Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I Mutation
Francois Pierre Combes, Sherwin K B Sy, Ying Fei Li, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2026
Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer
Yan Ji, Felix Huth, Craig Wang, et al.
Clinical Pharmacokinetics
|
October 29, 2024
Clinical Pharmacology of Asciminib: A Review
Matthias Hoch, Felix Huth, Paul William Manley, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
CPT: Pharmacometrics & Systems Pharmacology
|
March 10, 2020
Model-Informed Drug Development for Everolimus Dosing Selection in Pediatric Infant Patients
Francois Pierre Combes, Heidi J Einolf, Neva Coello, et al.
Journal of Pharmaceutical Sciences
|
February 6, 2019
Physiologically Based Pharmacokinetic Modeling to Supplement Nilotinib Pharmacokinetics and Confirm Dose Selection in Pediatric Patients
Tycho Heimbach, Wen Lin, Florence Hourcade-Potelleret, et al.
Clinical Pharmacokinetics
|
June 28, 2022
Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases
Ying Fei Li, Francois Pierre Combes, Matthias Hoch, et al.
Clinical Pharmacokinetics
|
August 17, 2022
Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases
Ying Fei Li, Francois Pierre Combes, Matthias Hoch, et al.
Clinical Pharmacokinetics
|
June 23, 2026
Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer
Yan Ji, Craig Wang, Francois Pierre Combes, et al.
Clinical Pharmacokinetics
|
September 7, 2024
Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I Mutation
Francois Pierre Combes, Sherwin K B Sy, Ying Fei Li, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2026
Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer
Yan Ji, Felix Huth, Craig Wang, et al.
Clinical Pharmacokinetics
|
October 29, 2024
Clinical Pharmacology of Asciminib: A Review
Matthias Hoch, Felix Huth, Paul William Manley, et al.
Page
of 1